Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Clin Pharmacol Ther. 2014 Dec 4;97(2):167–176. doi: 10.1002/cpt.5

Table 1.

Women and neonatal demographics and gestational data.

Characteristic Mean (SD)
Or n
Range
Number of subjects
Pregnant 40
Nonpregnant 20
Total 60

Number of subjects on 4 mg or 8 mg dose
Pregnant 10/30
Nonpregnant 10/10
Total 20/40

Age (years)
Pregnant 33.0 (5.2) 23–43
Nonpregnant 37.7 (5.7) 26–45
Total 34.6 (5.8) 23–45

Weight (kg)
Pregnant 80.7 (12.0) 60–115
Nonpregnant 71.1 (20.5) 51–126
Total 77.5 (15.8) 51–126

Height (m)
Pregnant 1.64 (0.06) 1.5–1.75
Nonpregnant 1.63 (0.06) 1.4–1.73
Total 1.64 (0.06) 1.44–1.75

Gestation period (weeks) 39.1 (0.746) 36.4– 40.4

Delay until delivery after dose (min) 80.8 (55.5) 8.0–333

Number of neonates 38

Weight of neonate at birth(kg) 3.49 (0.49) 2.47–4.58

Height of neonate at birth (cm) 50.5 (2.12) 46–55

Neonatal Gender (n)
  Male 18
  Female 20